Revenue and Operating Performance
Docmode Health’s net sales have shown a robust upward trend, rising from ₹12.42 crores in March 2022 to ₹41.77 crores by March 2025. This growth reflects a more than threefold increase over three years, signalling expanding market presence and sales traction. Total operating income mirrored this trend, with no other operating income reported during this period.
However, the company’s expenditure profile reveals some challenges. While raw material costs were nil, the purchase of finished goods surged dramatically to ₹44.77 crores in March 2025 from just ₹1.05 crores in March 2022, indicating a shift in procurement or inventory strategy. Employee costs have slightly decreased from ₹5.56 crores in March 2023 to ₹3.76 crores in March 2025,...
Read More





